Novo Nordisk sued two compounding pharmacies in Florida for allegedly selling impure and "potentially unsafe" drugs claiming ...

Novo Nordisk—manufacturer of diabetes and weight-loss drugs Ozempic and Wegovy—filed lawsuits against two pharmacies after tests concluded their products were impure, according to an ...

The school district is self-insured, meaning it foots the bill for the health care costs of employees. As many as 3,500 ...

Eli Lilly and Company, Novo Nordisk and Sanofi, which the board in an executive summary refers to as “the Insulin Cartel,” ...

A Pennsylvania mom is suing the maker of Ozempic and Wegovy claiming she nearly died from taking the prescription drugs and ...

The 'big three' insulin producers Novo Nordisk, Eli Lilly ... The lawsuit also takes aim at the three largest pharmacy benefit managers (PBMs) in the US – CVS Caremark, Express Scripts, and ...

Novo Nordisk CEO to insurance companies and pharmacy benefit managers as significant contributors to high out-of-pocket costs. Jørgensen expressed willingness to testify before the Senate committee.

PBMs have become powerful gatekeepers in the prescription drug market, dictating which medications are covered and at what cost. Several state and local governments have filed lawsuits against ...

Employers and employees spent more than $400 billion on obesity care in 2023; Novo Nordisk's CEO said weight ... about 60% of U.S. list prices after pharmacy benefit managers take rebates and ...

Sun Pharma of India and Mylan Pharmaceuticals of West Virginia seek FDA approval of generic versions of the popular ...

LONDON/NEW YORK (Reuters) - As Eli Lilly's weight-loss drug Zepbound gains ground in the U.S. against Novo Nordisk's Wegovy ... patients actually get at the pharmacy? Lilly has quickly built ...

Noom said that it plans to offer a compounded formulation of Novo Nordisk’s (NVO ... which are made by special pharmacies and not reviewed by the FDA. Noom said it has partnered with a 503B ...